Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection
NCT00004757Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Aug 1992
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of aciclovir in herpes simplex virus type 2 infection, sponsored by National Center for Research Resources. Started Aug 1992; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes simplex virus type 2 infection
Beyond the preview
Go deeper on NCT00004757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004757.